Not logged in.png)
Share.png)
SaveShare Save PK/PD analysis of pembrolizumab, nivolumab and atezolizumab in NSCLC patients: The PIONeeR trial
Ciccolini, J.; Hamimed, M.; Marolleau, S.; Perez, C.; Benzekry, S.; Le Ray, M.; Boyer, A.; Audigier-Valette, C.; Martinez, S.; Pegliasco, H.; Ray, P.; Falchero, L.; Serre, A.; Cloarec, N.; Lebas, L.; Hominal, S.; Mazieres, J.; Perol, M.; Greillier, L.; Barlesi, F. Share Save Share Save Share Save DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancerLe, Thi Khanh; Cherif, Chaima; Omabe, Kenneth; Paris, Clement; Lannes, Francois; Audebert, Stephane; Baudelet, Emilie; Hamimed, Mourad; Barbolosi, Dominique; Finetti, Pascal; Bastide, Cyrille; Fazli, Ladan; Gleave, Martin; Bertucci, Francois; Taieb, David; Rocchi, Palma Share Save MOVIE: a phase I, open-label, multicenter study to evaluate the safety and tolerability of metronomic vinorelbine combined with durvalumab plus tremelimumab in patients with advanced solid tumorsVicier, C.; Isambert, N.; Cropet, C.; Hamimed, M.; Osanno, L.; Legrand, F.; Rouge, T. de La Motte; Ciccolini, J.; Goncalves, A. Share Save Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood-Brain Barrier DisruptionBerard, Charlotte; Desgranges, Stephane; Dumas, Noe; Novell, Anthony; Larrat, Benoit; Hamimed, Mourad; Taulier, Nicolas; Esteve, Marie-Anne; Correard, Florian; Contino-Pepin, Christiane Share Save Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low-grade gliomaHamimed, Mourad; Gattacceca, Florence; Andre, Nicolas; Tresch-Bruneel, Emmanuelle; Probst, Alicia; Chastagner, Pascal; Pagnier, Anne; De Carli, Emilie; Entz-Werle, Natacha; Grill, Jacques; Aerts, Isabelle; Frappaz, Didier; Bertozzi-Salamon, Anne-Isabelle; Solas, Caroline; Leblond, Pierre Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
